Contrast Induced Nephropathy (CIN) Unknown Status Phase 0 Trials for Ascorbic acid (DB00126)

Also known as: Contrast Induced Nephropathy

IndicationStatusPhase
DBCOND0066353 (Contrast Induced Nephropathy (CIN))Unknown Status0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01017796Contrast Agent-associated Nephrotoxicity in Intensive Care Unit PatientsPrevention